NLRP7 Antibody Blocking Peptide

• Reactivity: Hu
• Applications: AC
• Concentration: 0.2 mg/ml

NLRP7 Antibody Blocking Peptide Summary

• Description: A blocking peptide containing 18 amino acids near the amino terminus of human NALP7.

  Source: Synthetic

  (Accession #: NP_631915)

• Source: Synthetic
• Protein/Peptide Type: Antibody Blocking Peptide
• Gene: NLRP7
• Purity: N/A

Applications/Dilutions

• Dilutions:
  • Antibody Competition
• Application Notes: This peptide is useful as a blocking peptide for NBP1-76290.
  
  For further blocking peptide related protocol, click here.

Packaging, Storage & Formulations

• Storage: Store at -20C. Avoid freeze-thaw cycles.
• Buffer: PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
• Preservative: 0.02% Sodium Azide
• Concentration: 0.2 mg/ml
• Purity: N/A

Alternate Names for NLRP7 Antibody Blocking Peptide

• CLR19.4
• MGC126471
• NACHT, leucine rich repeat and PYD containing 7
• NACHT, LRR and PYD containing protein 7
• NACHT, LRR and PYD domains-containing protein 7
• NALP7
• NALP7MGC126470
• NLR family, pyrin domain containing 7
• NLRP7
• NOD12
• NOD12HYDM
• Nucleotide-binding oligomerization domain protein 12
• nucleotide-binding oligomerization domain, leucine rich repeat and pyrin domaincontaining 7
• PAN7
• PYPAF3
• PYPAF3FLJ94610
• PYRIN-containing APAF1-like protein 3

Background

Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily. LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Peptides and proteins are guaranteed for 3 months from date of receipt.

Bioinformatics

• Gene Symbol: NLRP7